Aerie Pharmaceuticals (AERI) stock Forecast for 2022 – 2026

Aerie Pharmaceuticals (AERI) stock Forecast for 2022 – 2026

Last update: October 6, 2022 (14:01)

Sector: Healthcare

The share price of Aerie Pharmaceuticals, Inc. (AERI) now

What analysts predict: $15.32

52-week high/low: $15.37 / $4.81

50/200 Day Moving Average: $12.44 / $8.73

This figure corresponds to the average price over the previous 50/200 days. For Aerie Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Aerie Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Aerie Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aerie Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Aerie Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Aerie Pharmaceuticals stock? When should I record a loss on Aerie Pharmaceuticals stock? What are analysts' forecasts for Aerie Pharmaceuticals stock? What is the future of Aerie Pharmaceuticals stock?

We forecast Aerie Pharmaceuticals stock performance using neural networks based on historical data on Aerie Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aerie Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aerie Pharmaceuticals shares. This happens once a day.





Historical and forecast chart of Aerie Pharmaceuticals stock

The chart below shows the historical price of Aerie Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aerie Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aerie Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 08 16.34 15.90 16.94 6.53
Oct 09 16.00 15.67 16.28 3.93
Oct 10 16.14 15.94 16.38 2.78
Oct 11 16.23 15.85 16.52 4.20
Oct 12 16.30 16.09 16.67 3.60
Oct 13 16.45 16.22 16.69 2.94
Oct 14 16.23 15.63 16.55 5.87
Oct 15 16.39 15.88 16.66 4.95
Oct 16 16.61 16.10 16.83 4.54
Oct 17 16.45 15.82 16.79 6.08
Oct 18 16.23 15.60 16.75 7.33
Oct 19 17.03 16.65 17.24 3.58
Oct 20 17.21 16.65 17.80 6.93
Oct 21 16.92 16.44 17.12 4.12
Oct 22 17.36 17.08 17.78 4.12
Oct 23 16.92 16.57 17.39 4.95
Oct 24 17.70 17.38 18.13 4.33
Oct 25 18.24 17.58 18.61 5.81
Oct 26 18.39 18.08 18.90 4.52
Oct 27 17.96 17.51 18.64 6.46
Oct 28 17.60 17.01 17.87 5.02
Oct 29 17.86 17.53 18.32 4.53
Oct 30 18.43 18.16 18.81 3.55
Oct 31 18.63 18.01 19.01 5.53
Nov 01 19.30 18.96 19.74 4.12
Nov 02 20.06 19.28 20.71 7.44
Nov 03 19.20 18.75 19.64 4.71
Nov 04 18.90 18.49 19.63 6.13
Nov 05 18.26 17.85 18.59 4.14
Nov 06 17.73 17.31 18.20 5.12

Aerie Pharmaceuticals Daily Price Targets


Aerie Pharmaceuticals Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $16.34. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 6.127%.

Pessimistic target level: 15.90

Optimistic target level: 16.94


Aerie Pharmaceuticals Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $16.00. Negative dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 3.784%.

Pessimistic target level: 15.67

Optimistic target level: 16.28


Aerie Pharmaceuticals Stock Forecast 10-10-2022.

Forecast target price for 10-10-2022: $16.14. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 2.710%.

Pessimistic target level: 15.94

Optimistic target level: 16.38


Aerie Pharmaceuticals Stock Forecast 10-11-2022.

Forecast target price for 10-11-2022: $16.23. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 4.027%.

Pessimistic target level: 15.85

Optimistic target level: 16.52


Aerie Pharmaceuticals Stock Forecast 10-12-2022.

Forecast target price for 10-12-2022: $16.30. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 3.472%.

Pessimistic target level: 16.09

Optimistic target level: 16.67


Aerie Pharmaceuticals Stock Forecast 10-13-2022.

Forecast target price for 10-13-2022: $16.45. Positive dynamics for Aerie Pharmaceuticals shares will prevail with possible volatility of 2.858%.

Pessimistic target level: 16.22

Optimistic target level: 16.69


AERI (AERI) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Nov. 17.64 16.65 19.05 12.59
Dec. 19.97 16.82 21.81 22.89

Aerie Pharmaceuticals forecast for this year


Aerie Pharmaceuticals Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $17.6416. Pessimistic: $16.65. Optimistic: $19.05


Aerie Pharmaceuticals Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $19.9703. Pessimistic: $16.82. Optimistic: $21.81




Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 19.21 16.18 21.94 26.27
Feb 18.79 17.25 21.04 18.04
Mar 20.18 17.15 21.31 19.51
Apr 22.92 20.08 23.84 15.77
May 23.70 20.76 25.46 18.44
Jun 24.60 23.47 25.78 8.97
Jul 25.19 21.72 28.17 22.90
Aug 29.38 26.20 31.02 15.53
Sep 27.79 25.40 30.85 17.66
Oct 23.79 20.03 26.36 24.01
Nov 23.50 20.12 24.58 18.16
Dec 22.00 19.27 23.98 19.63

Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 22.53 20.59 23.83 13.61
Feb 21.49 20.20 24.80 18.54
Mar 25.66 23.35 29.20 20.03
Apr 23.40 21.34 26.86 20.56
May 23.68 22.17 25.43 12.85
Jun 19.42 16.70 21.91 23.76
Jul 20.82 19.78 24.02 17.68
Aug 21.36 18.16 23.75 23.56
Sep 19.05 17.03 21.00 18.87
Oct 21.57 18.63 22.95 18.80
Nov 19.97 17.33 21.17 18.11
Dec 21.97 19.60 25.44 22.97



Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 25.22 21.89 28.85 24.13
Feb 23.91 22.23 27.73 19.83
Mar 20.18 18.56 22.40 17.12
Apr 21.63 18.30 24.96 26.69
May 19.99 18.43 22.07 16.49
Jun 22.99 19.31 25.93 25.53
Jul 21.79 18.30 25.10 27.08
Aug 20.48 18.60 21.30 12.69
Sep 23.02 22.06 26.06 15.37
Oct 23.07 20.39 26.48 23.00
Nov 27.50 26.23 28.98 9.49
Dec 28.98 25.97 30.78 15.63

Aerie Pharmaceuticals (AERI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 32.46 29.99 34.41 12.83
Feb 27.98 25.46 31.73 19.75
Mar 25.74 22.86 28.88 20.86
Apr 25.79 23.52 26.93 12.64
May 27.39 23.78 30.57 22.22
Jun 25.75 24.41 27.71 11.90
Jul 28.79 24.70 32.65 24.34
Aug 32.01 27.15 35.41 23.33
Sep 38.29 36.14 43.95 17.77
Oct 37.44 35.20 40.59 13.28
Nov 43.59 38.44 45.85 16.16
Dec 39.58 34.67 45.35 23.56

Aerie Pharmaceuticals information and performance

Aerie Pharmaceuticals Inc. (Nasdaq: AERI) is a publicly traded, clinical stage pharmaceutical company dedicated to discovering, developing and commercializing first-class treatments for patients with glaucoma and other eye conditions.

Aerie Pharmaceuticals Address

4301 EMPEROR BOULEVARD, SUITE 400, DURHAM, NC, US

Market Capitalization: 747 120 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -5 987 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.472

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.225

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.343

Enterprise Value (EV) /Revenue

EV To EBITDA: -226.02

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49412700

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.